Business Standard

Unjha Formulations Share Price

Know More
BSENSE

23.53 1.12 (5.00%)

12:00 AM,12th Jul 2024
Stock not traded

BSE : 531762

NSE :

Sector : Health care

ISIN Code : INE576D01015

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 12-Jul-2024 | 12:00 AM IST

Market Cap (₹ Cr)

11

Turnover (₹ Cr)

0.00

Volume (Shares)

12,565

Face Value

10

52-WK High

34.99

52-WK High Date

23-May-2024

52-WK Low

10.55

52-WK Low Date

26-Jul-2023

All Time High

34.99

All Time High Date

23-May-2024

All Time Low

1.00

All Time Low Date

08-Jul-1999

Unjha Formulations Ltd

Unjha Formulations Ltd was established in Jun.'87 as a partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat. It was promoted by Shambhubhai A Patel. The Company is a pioneer in Isabgol (Psyllium) Formulation. The Company is in service to Isabgol (Psyllium) Ayurvedic formulation profession. The company manufactures pharmaceutical formulations like liquids powder tablets capsules injectibles etc. It is one of the largest manufacturers of isabgul products in India. The company's products are classified under two divisions -- human consumption and veterinary products. Its parent company M/S Urvesh Ltd. is 100% EOU is engaged in exporting of Isabol Hus...
Read More

Unjha Formulations Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

11

EPS - TTM (₹) [S]

0.62

P/E Ratio (X) [S]

3.86

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]6.09
P/B Ratio (₹) [S]3.86

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

Date Broker Action Prices(₹) Report
Data Not Found

Stock Strength

Today's Low/High

21.75

23.53

Week Low/High

21.75

25.00

Month Low/High

21.75

29.00

Year Low/High

10.55

35.00

All time Low/High

1.00

35.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week1.29%%0.650.73%
1 Month-4.85%%5.115.06%
3 Month14.33%%8.458.80%
6 Month44.80%%10.9611.91%
1 Year106.77%%23.1326.40%
3 Year120.94%%53.7456.14%

Company Info

Company Information

Managing Director : Krutiben M Patel

Independent Director : Hasmukh C Chavda

Chairman (Non-Executive) : Jashodaben S Patel

Independent Director : Jitendrakumar Parshottamdas Limbachiya

Company Sec. & Compli. Officer : Jigar Ray

Independent Director : Mustufa Najmuddin

Additional Director : Esham. Patel

Registered Office: Khali Char Rasta, State Highway Ta Sidhpur,Patan,Gujarat-384151 Ph: 91-2767-282395

Email:info@unjhaformulations.com ; unjfor@bsnl.in

URL:http://www.unjhaformulations.com

FAQs about Unjha Formulations Ltd

1. What's the Unjha Formulations Ltd share price today?
Unjha Formulations Ltd share price was Rs 23.53 at close on 12th Jul 2024. Unjha Formulations Ltd share price was up by 5.00% over the previous closing price of Rs 22.41. Unjha Formulations Ltd share price trend:

  • Last 1 Month: Unjha Formulations Ltd share price moved down by 4.85% on BSE
  • Last 3 Months: Unjha Formulations Ltd share price moved up by 14.33% on BSE
  • Last 12 Months: Unjha Formulations Ltd share price moved up by 106.77% on BSE
  • Last 3 Years: Unjha Formulations Ltd price moved up by 120.94% on BSE


2. How can I quickly analyse the performance of the Unjha Formulations Ltd stock?
The performance of the Unjha Formulations Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 37.95
  • Price to book value ratio is 3.86
  • Dividend yield of 0.00
  • The EPS (trailing 12 months) of the Unjha Formulations Ltd stock is Rs 0.62


3. What is the market cap of Unjha Formulations Ltd?
Unjha Formulations Ltd has a market capitalisation of Rs 11 crore.


4. What is Unjha Formulations Ltd's 52-week high/low share price?
The Unjha Formulations Ltd’s 52-week high share price is Rs 34.99 and 52-week low share price is Rs 10.55.


5. Is the Unjha Formulations Ltd profitable?
On a consolidated basis, Unjha Formulations Ltd reported a loss of Rs -0.18 crore on a total income of Rs 4.44 crore for the quarter ended 2024. For the year ended Mar 2024, Unjha Formulations Ltd had posted a loss of Rs -0.18 crore on a total income of Rs 4.44 crore.


6. Which are Unjha Formulations Ltd’s peers in the Health care sector?
Unjha Formulations Ltd’s top 5 peers in the Health care sector are Parmax Pharma, Norris Medicines, Bacil Pharma, Unjha Formul., Kobo Biotech, Chemo Pharma Lab, Welcure Drugs.


7. Who owns how much in Unjha Formulations Ltd?
Key changes to the Unjha Formulations Ltd shareholding are as follows:

  • Promoter holding in Unjha Formulations Ltd has gone up to 36.93 per cent as of Jun 2024 from 36.93 per cent as of Sep 2023.